Form 4: LeMaitre Vascular Director Acquires Shares via Vesting

LeMaitre Vascular Director Bridget A. Ross acquired 1 share of common stock through the vesting and release of dividend equivalent rights.

Summary

• Bridget A. Ross, a Director at LeMaitre Vascular Inc. (LMAT), acquired 1 share of common stock on December 6, 2025.
• This acquisition was a result of the release of dividend equivalent rights (DERs) on a one-for-one basis, with a transaction price of $0 per share.
• Following this transaction, Ms. Ross directly beneficially owns 2,917 shares of LMAT common stock.
• Several dividend equivalent rights accrued on various restricted stock unit (RSU) and performance share unit (PSU) awards granted between December 2022 and December 2024.
• One dividend equivalent right was released on December 6, 2025, in connection with the vesting of an RSU award granted on December 6, 2024.

Sentiment

Score: 6

Explanation: The filing reports a routine insider acquisition of shares through vesting, which is generally a neutral to slightly positive signal as it indicates continued insider ownership and the successful maturation of equity compensation. There are no negative implications.

Positives

• Director Bridget A. Ross increased her direct beneficial ownership of LeMaitre Vascular Inc. common stock by 1 share, demonstrating continued alignment with shareholder interests.
• The acquisition of shares through vesting of dividend equivalent rights indicates the successful maturation of previously granted equity awards.

Future Outlook

This filing is a historical report of an insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing reports a routine insider transaction (vesting of equity awards) for a director of LeMaitre Vascular Inc., a medical device company. Such transactions are common across all industries as part of executive compensation and do not inherently reflect broader industry trends or competitive positioning.

Comparison to Industry Standards

• This filing reports a standard insider transaction related to equity compensation. It does not provide financial results or operational metrics that would allow for a direct comparison to industry benchmarks or specific comparable companies or projects.
• The vesting of equity awards is a common practice in executive compensation across publicly traded companies.

Corporate Governance

Related Party Transactions

• The filing reports the acquisition of shares by a director as part of an equity compensation plan, which is a common type of transaction between an insider and the company. No other related party transactions are disclosed.

Stakeholder Impact

• Shareholders: The acquisition of shares by a director through vesting can be seen as a positive signal, indicating continued alignment of interests between management and shareholders.
• Employees: The vesting of equity awards is a standard component of compensation packages, reinforcing employee retention and motivation.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where a director acquired shares through the vesting of equity awards. This is a standard part of executive compensation and does not provide new information that would significantly alter the investment thesis for LeMaitre Vascular Inc. It indicates continued insider ownership, which is generally a neutral to slightly positive signal, but not enough to warrant a change in recommendation based solely on this filing.

Keywords

LeMaitre Vascular, LMAT, Bridget A. Ross, Form 4, Insider Trading, Director, Stock Acquisition, Vesting, Dividend Equivalent Rights, Restricted Stock Units, Performance Share Units